John Burthem

1.7k total citations
51 papers, 1.2k citations indexed

About

John Burthem is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, John Burthem has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 18 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in John Burthem's work include Chronic Lymphocytic Leukemia Research (15 papers), Immunotherapy and Immune Responses (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). John Burthem is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Immunotherapy and Immune Responses (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). John Burthem collaborates with scholars based in United Kingdom, United States and Czechia. John Burthem's co-authors include JC Cawley, Karen Rees‐Unwin, Alain Pluen, Alexander P. Golovanov, David J. Roberts, Paula Bolton‐Maggs, Maria Proytcheva, Carol Briggs, Anthony D. Whetton and Gina Zini and has published in prestigious journals such as Blood, The Journal of Physical Chemistry C and Chemical Science.

In The Last Decade

John Burthem

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Burthem United Kingdom 19 376 367 266 234 211 51 1.2k
Brigitte Schoell Germany 14 1.3k 3.4× 102 0.3× 118 0.4× 132 0.6× 83 0.4× 16 2.2k
Neha Bhagwat United States 16 843 2.2× 272 0.7× 259 1.0× 151 0.6× 238 1.1× 42 1.4k
Bernd Romeike Germany 28 720 1.9× 412 1.1× 20 0.1× 313 1.3× 227 1.1× 105 2.2k
Aibin Liang China 19 689 1.8× 247 0.7× 114 0.4× 202 0.9× 131 0.6× 117 1.5k
Neil Ashley United Kingdom 21 1.3k 3.5× 147 0.4× 269 1.0× 393 1.7× 179 0.8× 33 2.3k
A. Schwartz United States 12 374 1.0× 98 0.3× 92 0.3× 185 0.8× 161 0.8× 16 766
M. Brereton United Kingdom 11 206 0.5× 39 0.1× 88 0.3× 114 0.5× 160 0.8× 22 701
Katharina Pachmann Germany 22 386 1.0× 78 0.2× 51 0.2× 164 0.7× 333 1.6× 106 1.9k
Luca Sorrentino Italy 20 413 1.1× 67 0.2× 137 0.5× 112 0.5× 258 1.2× 63 1.3k
Partha Ray United States 20 1.5k 3.9× 80 0.2× 128 0.5× 406 1.7× 222 1.1× 49 2.3k

Countries citing papers authored by John Burthem

Since Specialization
Citations

This map shows the geographic impact of John Burthem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Burthem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Burthem more than expected).

Fields of papers citing papers by John Burthem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Burthem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Burthem. The network helps show where John Burthem may publish in the future.

Co-authorship network of co-authors of John Burthem

This figure shows the co-authorship network connecting the top 25 collaborators of John Burthem. A scholar is included among the top collaborators of John Burthem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Burthem. John Burthem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reitsma, Stéphanie E., Lori A. Holle, Dougald M. Monroe, et al.. (2023). Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency. Journal of Thrombosis and Haemostasis. 21(3). 467–479. 7 indexed citations
2.
Hutchinson, Claire V., M. Brereton, Julie E. Adams, et al.. (2021). The Use and Effectiveness of an Online Diagnostic Support System for Blood Film Interpretation: Comparative Observational Study. Journal of Medical Internet Research. 23(8). e20815–e20815. 1 indexed citations
3.
Borsley, Stefan, Flavio della Sala, Jonathan Clayden, et al.. (2020). Switchable foldamer ion channels with antibacterial activity. Chemical Science. 11(27). 7023–7030. 48 indexed citations
4.
Holle, Lori A., et al.. (2018). Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency. Blood Advances. 2(10). 1076–1088. 37 indexed citations
5.
Burthem, John, et al.. (2018). Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia. Journal of Hematology. 7(1). 7–13. 4 indexed citations
6.
Burthem, John, et al.. (2018). ASP2215 in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia with FLT3 Mutation: Background and Design of the ADMIRAL Trial. Future Oncology. 14(20). 1995–2004. 24 indexed citations
7.
Burthem, John, et al.. (2016). Graphene in therapeutics delivery: Problems, solutions and future opportunities. European Journal of Pharmaceutics and Biopharmaceutics. 104. 235–250. 196 indexed citations
8.
Salle, Barbara De la, et al.. (2016). Web-Based Virtual Microscopy of Digitized Blood Slides for Malaria Diagnosis: An Effective Tool for Skills Assessment in Different Countries and Environments. Journal of Medical Internet Research. 18(8). e213–e213. 9 indexed citations
9.
10.
Hutchinson, Claire V., et al.. (2014). Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture. Experimental Hematology and Oncology. 3(1). 7–7. 5 indexed citations
11.
Karimiani, Ehsan Ghayoor, et al.. (2013). Single-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Experimental Hematology. 42(3). 183–191.e5. 16 indexed citations
12.
Brereton, M., Barbara De la Salle, John Burthem, et al.. (2008). Review of the UK NEQAS (H) digital morphology pilot scheme for continuing professional development accessed via the internet. International Journal of Laboratory Hematology. 30(5). 365–371. 10 indexed citations
13.
Bhavnani, M., Jeffrey Braithwaite, John Burthem, et al.. (2008). British Society for Haematology, Slide session, Annual Scientific Meeting, Bournemouth, 2007. International Journal of Laboratory Hematology. 30(2). 95–104. 13 indexed citations
14.
Griffiths, Stephen D., John Burthem, Richard D. Unwin, et al.. (2007). The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Molecular Biotechnology. 36(2). 81–89. 27 indexed citations
15.
Hutchinson, Claire V., M. Brereton, & John Burthem. (2005). Digital imaging of haematological morphology. Clinical & Laboratory Haematology. 27(6). 357–362. 15 indexed citations
16.
Smith, Duncan L., John Burthem, & Anthony D. Whetton. (2003). Molecular pathogenesis of chronic myeloid leukaemia. Expert Reviews in Molecular Medicine. 5(27). 1–27. 12 indexed citations
17.
Burthem, John, Mirko Zuzel, & John C. Cawley. (1997). WHAT IS THE NATURE OF THE HAIRY CELL AND WHY SHOULD WE BE INTERESTED?. British Journal of Haematology. 97(3). 511–514. 13 indexed citations
18.
Burthem, John, et al.. (1996). Integrin Receptors and Hairy Cell Leukaemia. Leukemia & lymphoma. 21(3-4). 211–215. 4 indexed citations
19.
Burthem, John, et al.. (1994). The function of c-fms in hairy-cell leukemia: macrophage colony- stimulating factor stimulates hairy-cell movement. Blood. 83(5). 1381–1389. 2 indexed citations
20.
Burthem, John & JC Cawley. (1994). Specific tissue invasion, localisation and matrix modification in hairy-cell leukemia.. PubMed. 14 Suppl 1. 19–22. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Schoell Breakdown of academic impact, for papers by Neha Bhagwat Breakdown of academic impact, for papers by Bernd Romeike Breakdown of academic impact, for papers by Aibin Liang Breakdown of academic impact, for papers by Neil Ashley Breakdown of academic impact, for papers by A. Schwartz Breakdown of academic impact, for papers by M. Brereton Breakdown of academic impact, for papers by Katharina Pachmann Breakdown of academic impact, for papers by Luca Sorrentino Breakdown of academic impact, for papers by Partha Ray
Rankless by CCL
2026